Indrani Egleston appointed as the new Chief Financial Officer by ECRI.
In a significant move for the healthcare industry, Indrani Egleston has been named the new Chief Financial Officer (CFO) at ECRI, an independent nonprofit organisation dedicated to improving the safety, quality, and cost-effectiveness of care across all healthcare settings. With over 25 years of experience in financial and strategic management, Egleston's expertise will be instrumental in supporting ECRI's mission to improve healthcare safety and quality.
ECRI, respected and trusted by healthcare leaders and agencies worldwide for its work in technology evaluation and safety, has built its reputation on integrity and disciplined rigor. The organisation is federally certified as a Patient Safety Organization by the U.S. Department of Health and Human Services and operates locations in the U.S., Netherlands, United Kingdom, Malaysia, UAE, and Canada.
One of ECRI's most significant acquisitions was The Institute for Safe Medication Practices (ISMP) in 2020, which aimed to address medication errors. Another strategic move was the acquisition of The Just Culture Company in 2024 to transform healthcare workplace cultures.
Egleston's career trajectory shows extensive experience in strategic financial leadership, which now informs her impact on healthcare. Prior to joining ECRI, she held advancing financial leadership positions at large public companies, including Covia Corporation and Nordson Corporation. She also has a Master of Business Administration from Case Western Reserve University and a Bachelor of Business Administration from the University of Michigan.
In her new role, Egleston will bring her expertise in critical financial disciplines that are instrumental for sustaining and growing organisations focused on healthcare improvement, including internal audits and mergers and acquisitions (M&A), which can affect scaling patient safety technologies and initiatives.
ECRI's Associate Director of Strategic Communications, Yvonne Rhodes, can be contacted at [email protected] for further information.
Indrani Egleston's impact on healthcare is primarily through her leadership at ECRI, a leading entity in risk mitigation and evidence-based healthcare. Her strategic financial leadership will help ECRI maintain and expand its work in advancing patient safety, ultimately facilitating safer healthcare delivery systems.
References: [1] ECRI Press Release, July 2025 [3] ECRI Website, Accessed July 2025
- Egleston's experience in financial and strategic management will be crucial in supporting ECRI's mission to minimize errors and enhance health care quality and safety.
- With its focus on technology evaluation, safety, and research, ECRI has earned a reputation for trust and integrity among healthcare leaders and agencies.
- ECRI's acquisition of The Institute for Safe Medication Practices in 2020 was significant in its efforts to tackle medication errors.
- The acquisition of The Just Culture Company in 2024 was another strategic move by ECRI to transform healthcare workplace cultures.
- Egleston holds an MBA from Case Western Reserve University and a BBA from the University of Michigan, as well as a history of financial leadership roles at large business entities.
- Egleston's expertise lies in critical financial disciplines such as internal audits and M&As, which can contribute to scaling patient safety technologies and initiatives.
- To gather more information about ECRI and its new CFO, one can contact Yvonne Rhodes at [email protected].
- Egleston's leadership at ECRI, a key player in health-and-wellness and risk mitigation, aims to advance patient safety and foster safer healthcare delivery systems.
- The news of Egleston's appointment and ECRI's accomplishments can be found in various finance and health-related news and analytics sources, as well as on the ECRI website.
